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Summary
Phase variation of the major ureaplasma surface
membrane protein, the multiple-banded antigen
(MBA), with its counterpart, the UU376 protein, was
recently discussed as a result of DNA inversion
occurring at speciﬁc inverted repeats. Two similar
inverted repeats to the ones within the mba locus
were found in the genome of Ureaplasma parvum
serovar 3; one within the MBA N-terminal paralogue
UU172 and another in the adjacent intergenic spacer
region. In this report, we demonstrate on both
genomic and protein level that DNA inversion at these
inverted repeats leads to alternating expression
between UU172 and the neighbouring conserved
hypothetical ORF UU171. Sequence analysis of this
phase-variable ‘UU172 element’ from both U. parvum
and U. urealyticum strains revealed that it is highly
conserved among both species and that it also
includes the orthologue of UU144. A third inverted
repeat region in UU144 is proposed to serve as an
additional potential inversion site from which chi-
meric genes can evolve. Our results indicate that site-
speciﬁc recombination events in the genome of U.
parvum serovar 3 are dynamic and frequent, leading
to a broad spectrum of antigenic variation by which
the organism may evade host immune responses.
Introduction
Ureaplasma (U.) urealyticum and U. parvum are mem-
bers of the class Mollicutes, commonly referred to as
mycoplasmas. Both species are commensals of the
human urogenital tract and of newborn infants and are
gaining recognition as important opportunistic pathogens
during pregnancy (Naessens et al., 1987; Gray et al.,
1992; Cassell et al., 1993; Abele-Horn et al., 1997; Yoon
et al., 1998; Vogel et al., 2006). There are four distinct U.
parvum serovars (1, 3, 6 and 14) and 10 U. urealyticum
serovars (2, 4, 5, 7–13). Genetic analysis has led to the
division of human ureaplasmas into these two species on
the basis of differences in genome size (Robertson et al.,
1990), DNA/DNA hybridization (Christiansen et al., 1981)
and restriction fragment length polymorphisms (Harasawa
et al., 1991). In addition, the 16S rRNA gene, the 16S–
23S rRNA intergenic regions, genes for subunits of the
urease gene and the multiple-banded antigen (MBA)
gene are used to deﬁne species and subtypes (Robertson
et al., 1993; Knox et al., 1998; Harasawa and Kanamoto,
1999; Kong et al., 1999; 2000a,b).
The MBA is a distinct size-variable surface protein
expressed by both Ureaplasma species and was there-
fore proposed to play a major role in antigenic variation
and virulence (Zheng et al., 1995). The mba gene con-
sists of a conserved part encoding both a signal peptide
and a membrane anchor, and a variable part, encoding a
number of uniform repeating units. In U. parvum serovar
3, each unit comprises the six amino acids QPAGKE. Size
variation of the MBA protein, which occurs both in vivo
and in vitro, is caused by alterations in the number of
repeat units (Teng et al., 1994; Zheng et al., 1994; 1995),
an event that is attributed to slipped-strand mispairing
(illegitimate recombination).
A recent report demonstrated how MBA-negative
mutants were obtained from U. parvum serovar 3 and U.
urealyticum serovar 5 through selection by applying pres-
sure with MBA-speciﬁc antibodies (Monecke et al., 2003).
Furthermore, it was shown that the mba gene is alternat-
ing in expression with its adjacent ORF UU376 and that
the 5′ region of the mba gene, which encodes the poten-
tial membrane anchor, can be fused to either ORF via a
DNA inversion event presumably occurring at short inver-
sion sequences (Zimmerman et al., 2009). We therefore
postulated that the two ORFs UU375 and UU376 belong
to a gene family composing the mba locus.
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terminal paralogue ORFs (UU172, UU189, UU483,
UU487 and UU526) have been annotated in U. parvum
serovar 3 (strain ATCC 700970) (Glass et al., 2000), all of
which show high sequence similarity in the 5′ region,
which encodes both signal peptide and the potential
membrane anchor. Among these ﬁve MBA N-terminal
paralogues, UU172 and its adjacent ORF UU171 both
show striking similarity to the mba locus. Both ORFs are
oriented in opposite direction and UU171, which was
originally annotated as ‘conserved hypothetical’, shows
high sequence similarity to UU376 (residues 1–187 are
60% similar to residues 45–224 of UU376). Moreover, two
inverted repeats can be located in this region; one in the
5′ sequence of UU172 and another in the intergenic
spacer region between UU172 and UU171. The resem-
blance of this UU172 element to the mba locus indicated
that it too might undergo alternating expression.
To date, the genomes of the two U. parvum serovar 3
strains ATCC 700970 (Accession No. AF222894) (Glass
et al., 2000) and type strain ATCC 27815T (Accession No.
CP000942), and the genome of U. urealyticum serovar 10
strainATCC 33699 (Accession No. CP001184) have been
completely sequenced. Moreover, draft assemblies are
available for the remaining U. parvum and U. urealyticum
serovars (J. Craig Venter Institute). In all 14 serovars,
orthologues of the ORFs UU171 and UU172 exist, and
the sequences are highly conserved among them. When
aligning these particular genomic regions of all 14 sero-
vars, two major observations can be made: ﬁrst, an inver-
sion quite similar to the one described for the mba locus of
serovar 3 can be seen among the mentioned ORF clus-
ters of the serovars and second, a major part of the
sequence of the ORF annotated as UU144 in serovar 3 is
fused to the equivalent of UU171 in all other serovars.
Only in the two sequenced serovar 3 strains are the two
ORFs UU171 and UU144 separated/fractionated by a
large genomic region of over 20 kb.
Since to date only one sequence is publicly available for
each serovar, it was unclear whether the observed inver-
sions of the UU172 element among the serovars had
occurred in a common ancestor, or whether it is a fre-
quently ongoing process occurring within proliferating
populations. The objective of this study was therefore to
provide evidence on both the genetic and protein level,
that the proposed phase switching between UU172 and
UU171 is an event occurring within deﬁned clonal popu-
lations and that the phase switching equally occurs in both
Ureaplasma species. In addition, our intention was to
detect protein expression of the hypothetical ORFs
UU171 and UU144.
To avoid confusion and to facilitate reading, the ORFs
described in this report were named according to the
locus tags deﬁned for U. parvum serovar 3 strain ATCC
700970 (Glass et al., 2000). As a result of our ﬁndings
about what we describe as the UU172–UU171–UU144
phase-variable element, these genes have been re-
annotated in the ureaplasma genome sequences now in
public databases.
Results
Organization of the UU172 element in Ureaplasma
serovars and clonal variants of U. parvum serovar
3 isolates
To determine the genomic organization of the UU172
element in U. parvum serovar 3 clonal isolates, genomic
DNA was extracted from clonal variants of ﬁve strains
(M14, V890, V397, DR1 and V892), digested with BglII,
and their UU172 loci were cloned in Escherichia coli and
sequenced. In strain ATCC 700970, BglII restriction sites
are located in the surrounding hypothetical ORFs UU168
and UU173 and they generate a 6731 bp fragment. None
of the investigated strains showed a similar gene arrange-
ment to that of strain ATCC 700970 or strain ATCC
27815T. In the ﬁve investigated strains, the sequence of
UU144 was located adjacent to the sequence of UU171
(Accession No. FN601249, FN601251, FN601252,
FN601253, FN601255).
BLAST analyses revealed that UU144, UU171 and
UU172 exist as orthologues in all 14 described Urea-
plasma serovars (Tables S1 and S2); however, a UU171/
UU144 fusion disrupted by a 20 kb region is only present
in the two sequenced serovars 3 strains, but in none of the
other U. parvum or U. urealyticum serovars. The ﬁve
conﬁgurations of the UU172 element observed in clinical
isolates and in the 14 described serovars are illustrated in
Fig. 1.
Expression of potential membrane proteins encoded in
the UU172 element
The ﬁndings of the BLAST analyses and the sequence data
indicate that the two ORFs UU144 and UU171 compose
one potential reading frame (UU171/144) in the investi-
gated isolates – with the exception of V892-K2 – and
together with UU172 comprise one phase-variable locus,
where the N-terminal part of UU172 (UU172N) undergoes
inversion. To prove this, four recombinant fusion proteins
were synthesized (Table S3, Fig. 2) and used to generate
monospeciﬁc hyperimmune antisera (Pabs) in rabbits for
Western blot analyses. Pab a-U172N was generated to
detect all possible protein variations before and after the
suggested DNA inversion. The recombinant protein
U172N comprised 102 amino acids of the N-terminal
region of UU172. The ﬁrst 30 amino acids were omitted,
as they encode a potential signal sequence, which is
conserved among the ﬁve MBA N-terminal paralogues in
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DNA inversion sequences within UU172 and UU144 were
also omitted to avoid possible cross-reactivity of Pabs in
immunoblots.
The puriﬁed recombinant fusion proteins were cleaved
from MalE with Factor Xa for use in Western blots to test
the reactivity of the Pabs. All proteins were detected
by their ‘corresponding’ Pabs which did not cross-react
(Fig. S1). Pab a-U171, however, cross-reacted with the
protein encoded by UU376 (Fig. S2), due to high
sequence similarity. This cross-reactivity was particularly
observed in Western blots of total protein of strains M14
and V892 (Fig. 3), which showed a higher expression rate
of UU376 than the other strains (Zimmerman et al., 2009).
Fig. 1. Arrangements of the UU172 element in U. parvum and U. urealyticum. Schematic illustration of the UU172 element in (A′) U. parvum
serovar 3 strain ATCC 700970 and strain ATCC 27815
T and the corresponding locus in (A–D) clonal variants of clinical isolates of U. parvum
serovar 3 and other U. parvum (U. p.) and U. urealyticum (U. u.) strains [a: reference (Glass et al., 2000); b: sequence information of the J.
Craig Venter Institute]. ser.: Ureaplasma serovars. Black arrow: potential promoter of the UU172 gene locus. ira and irb: intergenic spacer
regions. Crossing between A and B: suggested DNA inversion. Molecular weights were calculated on the basis of amino acid sequences.
Fig. 2. Schematic illustration of the disrupted UU172 element of U. parvum serovar 3 strain ATCC 700970 showing the ORFs UU172, UU171
and UU144 and the intergenic region (ir) between UU172 and UU171. Triangles and diamonds represent inverted repeat regions, where the
diamond indicates a palindromic sequence; corresponding DNA and encoding amino acid sequences, as they appear in U. parvum and U.
urealyticum, are shown above.
P/U: nucleotides found in U. parvum and U. urealyticum serovars 2, 4 and 12.
U: nucleotides in U. urealyticum
strains except serovars 2, 4 and 12. Primers (designated as numbers) used for generating recombinant proteins and monospeciﬁc Pabs used
for their detection are indicated (see Table S3).
Phase variation of the UU172 locus of Ureaplasma parvum 665
© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 79, 663–676To determine protein expression of the UU172 loci in
the investigated strains, all four monospeciﬁc Pabs were
used for immunostaining of total protein from clonal vari-
ants of U. parvum serovar 3 (27815T-K5, DR1-K1, M14-
K16 and V892-K2) and from U. urealyticum serovars 9, 10
and 12 (Fig. 3). Although all clonal variants showed pre-
dominant expression of a speciﬁc protein, some also
showed weak expression of truncated proteins or of pro-
teins deriving from alternating expression. The clonal
variant DR1-K1 showed a strong reaction of UU172, but
also showed a faint band of the fusion protein UU171/144
(Fig. 3, lane 2). The clonal variant M14-K16 showed a
strong band of the fusion protein UU171/144, but also
expressed a truncated UU172 protein (Fig. 3, lane 3). The
UU172 protein is truncated in this variant, due to a non-
sense mutation at position 1132 in the UU172 ORF
(Accession No. FN601250). Protein expression of the
three U. urealyticum serovars 9, 10 and 12 was in agree-
ment with their GenBank sequences; i.e. serovars 9 and
12 predominantly expressed UU172 and serovar 10
expressed UU171/144. A faint band was also observed in
Western blots of total protein of serovar 10 when reacting
with Pab a-U171 (Fig. 3, lane 6), which might be a trun-
cated UU171/144 protein.Also, serovar 10 showed a faint
reaction of UU172, indicating that alternate gene expres-
sion within the UU172 element likewise had occurred in
this strain. Faint bands obtained with Pab a-U172C could
also be observed in several strains/variants between 34
and 43 kDa. These bands appeared at the same molecu-
lar weight as the truncated UU172 protein of M14-K16,
indicating that the mutation at this site might be a fre-
quently occurring event. The clonal variant 27815T-K5
showed a positive signal only for the UU172 protein, while
expression of the UU144 and UU171 proteins were not
detected (Fig. 3, lane 1).
To show that the two proteins UU172 and UU171/144
are potential membrane proteins, Triton X-114 phase par-
titioning was carried out with total protein from strains DR1
and M14. Both hydrophilic and hydrophobic fractions
were investigated by Western blot analysis with the four
Pabs (Fig. 4). To qualitatively test for the efficiency of the
protein fractionation, one nitrocellulose membrane was
treated with a monoclonal antibody directed against the
cytosol aminopeptidase AmpL, encoded by UU507.
Western blot analysis showed that both the UU172 protein
of strain DR1 and the fusion protein UU171/144 of strain
M14 are hydrophobic. A number of cleavage products or
proteins of variable length could be observed in the hydro-
phobic fractions with Pabs a-U171, a-U172N and
a-U172C. A double band of the UU172 protein could also
be detected in the hydrophilic fraction of strain DR1 with
Pabs a-U172C and a-U172N, probably as a result of
Fig. 3. Western blot analyses of total Ureaplasma cell protein. U. parvum serovar 3 clonal variants: lane 1, 27815
T-K5; lane 2, DR1-K1; lane
3, M14-K16; lane 4, V892-K2; U. urealyticum: lanes 5–7, serovars 9, 10 and 12 respectively. Proteins were detected with monospeciﬁc Pabs
(see Table S3) indicated below the blots. Asterisks: cross-reactivity with UU376 protein.
Fig. 4. Western blot analyses of Triton X-114 phase partitioned total protein of U. parvum serovar 3 strains DR1 and M14. Lanes 1 and 2,
hydrophilic fractions of DR1 and M14 and lanes 1′ and 2′, hydrophobic fractions of DR1 and M14 respectively. Proteins were detected with
monospeciﬁc Pabs (see Table S3) indicated below the blots. a-AmpL is a monoclonal antibody against the cytosol aminopeptidase (UU507).
Open triangle: background bands in the hydrophilic phases which were already detectable with pre-immune sera (Fig. S6).
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were, however, found in the hydrophobic fraction. The
observed double band indicates that the protein had
been processed and cleaved from its potential signal
peptide.
Phase variation in expression of the UU172 element
during selective antibody pressure
To investigate whether the UU172 element is phase-
variable within propagating populations, clonal variants
of U. parvum serovar 3 were passaged three times in
broth containing Pabs directed either against the
C-terminal region of the UU172 protein (Pab a-U172C)
or against the fusion protein UU171/144 (Pab a-U144).
The clonal variants 27815T-K5 and DR1-K1 were
exposed to Pab a-U172C and clonal variant M14-K16
was exposed to Pab a-U144. Expression of UU172 and
UU171/144 was monitored by Western blot analysis and
in colony blots. Both techniques revealed that the anti-
body treatment led to the emergence of escape variants
expressing alternate proteins that had not been the
targets of selective pressure. Selective pressure against
the fusion protein UU171/144 in M14-K16 yielded clones
predominantly expressing UU172 (Fig. 5A and A′) and
selective pressure against UU172 yielded clones pre-
dominantly expressing the fusion protein UU171/144 in
DR1-K1 (Fig. 5B) and UU171 in 27815T-K5 (Fig. 5C). In
all cases, proteins were always expressed as fusions
with the N-terminal part of UU172. A frequently observed
variation was a truncated UU172 (UU172mut) protein or
a truncated form of UU172 comprising only the
N-terminal part of UU172 (UU172N). The latter could
also be observed in the strains V890 and V397 (Fig. S3)
(Accession No. FN601251, FN601252), where an inser-
tion of an additional thymidine at the potential inversion
sequence led to a nonsense mutation, resulting in a stop
codon in the 3′ region of UU172N.
Fig. 5. Phase variation of clonal variants of U. parvum serotype 3 before and after exposure to monospeciﬁc Pabs.
A–C. Western blot analyses of: (A) M14-K16 before (P0) and after (P3) serial exposure to Pab a-U144, (B) DR1-K1 before and after serial
exposure to Pab a-U172C, and (C) 27815
T-K5 before and after exposure to Pab a-U172C. Proteins were detected with monospeciﬁc Pabs
(see Table S3) indicated below the blots. Black triangles: cross-reaction with the UU376 protein. Open triangles: background bands, which
were already detectable with pre-immune sera.
A′. Colony immunoblots of M14-K16 before and after serial exposure to Pab a-UU144. Cells were plated before antibody treatment (P0) and
after the third passage (P3) after antibody treatment. Scale bar: 1 mm. For immunostaining, monospeciﬁc Pabs (see Table S3) indicated below
the blots were used.
D. Colony immunoblots showing sectored colonies of subclonal populations of M14-K16, which had been exposed to Pab a-U144. Double
immunoﬂuorescence overlay: green (bright) sectors, UU171/144 expression and red (dark) sectors, UU172 expression.
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against the three U. urealyticum strains or against clonal
lineages of these did not select for clones with alternating
expression. However, colony and Western blots showed
that altered gene expression likewise occurred in clonal
variants of serovars 9 and 10, even without antibody
pressure (not shown).Altered expression was observed in
onetothreecellsper100cellsinclonalvariantsofserovars
9 and 10; i.e. approximately 1% of the clones of serovar 9
expressed UU171/144 and approximately 1% of serovar
10 expressed UU172. Similar results were obtained for
subclonal lineages deriving from clonal variants DR1-K1
and M14-K16. Reversion of phase variation was observed
in subclonal populations of antibody-treated M14-K16
using the double immunoﬂuorescence technique to immu-
nostain colony blots, as shown in Fig. 5D by the sectored
expression of UU171/144 in predominantly UU172-
expressing colonies after exposure of cells to Pab a-U144.
Site-speciﬁc DNA inversion within the UU172 element
leads to alternate phase variation between UU172
and UU171
The conﬁguration of the UU172 element, before and after
antibody treatment, was characterized in the two clonal
variants 27815T-K5 and M14-K16 by Southern blot analy-
sis (Fig. 6). Genomic DNA was extracted from cells that
had been cultivated at standard growth conditions and
from cells that had been passaged three times in the
presence of either Pab a-U172C or Pab a-U144.
Genomic DNA was digested with the site-speciﬁc endo-
nucleases BglII and HincII, and the orientation of the 5′
region of UU172 (UU172N) and the intergenic spacer
region upstream of UU172 (irb) was monitored by South-
ern blot hybridization of the DNA fragments with a probe
directed against the UU172N sequence. Additionally, the
orientations of the sequences encoding UU171 and the
C-terminal part of UU172 were detected with probes tar-
geting the UU171 and U172C sequences respectively.
In strain ATCC 27815T, the ORF UU171 has a HincII
restriction site at its 3′ terminus, which is missing in the
strains where the UU171 and UU144 sequences are
fused. The choice of restriction sites allowed excision and
partitioning of the UU172 element into two fragments. In
both strainsATCC 27815 and M14, a HincII restriction site
lies within the intergenic spacer region irb, just behind one
of the postulated inversion site (Fig. 6A and B). Inversion
of the UU172N/irb region causes a relocation of the HincII
site, leading to altered fragment lengths. Southern blot
analysis showed that two locus conﬁgurations preferen-
Fig. 6. DNA inversion in the UU172 element of U. parvum serotype 3 clonal variants 27815
T-K5 and M14-K16. Schematic illustration of the
DNA inversion event in (A) 27815
T-K5 and (B) M14-K16. Southern blot analyses of (A′) 27815
T-K5 before (P0) and after (P3) selective
pressure with Pab a-U172C and (B′) M14-K16 before and after selective pressure with Pab a-U144. Genomic DNA was digested with BglII
and HincII and hybridized with the DIG-11-dUTP-labelled probes (see Table S3) indicated below the blots.
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the UU172N/irb region in front of UU172C, and the other
with this region inverted and located in front of UU171.
The majority of the population of 27815T-K5 grown under
standard conditions had the locus conﬁguration where
UU172N was fused with UU172C. Only a single band of
the expected 2506 bp was detected with the probe
against the UU172N sequence (Fig. 6A′). After antibody
treatment, inversion of the UU172N/irb region resulted in a
band of 1218 bp. The faint band of 636 bp observed in
Fig. 6A′, when detected with probe #171, indicated that
a minor population still contained the original locus
conﬁguration. By cloning of genomic DNA of 27815T-K5
after antibody pressure clones with an inverted sequence
were obtained (Accession No. FN601248). The same
inversion was observed in clonal variant DR1-K1 (Acces-
sion No. FN601254). In clonal variant M14-K16, inversion
of the UU172N/irb region after treatment with Pab a-U144
resulted in a single band of 2506 bp in blots probed with
#172N. Inversion of the suggested region was proven with
all three probes (Fig. 6B′) and by sequencing of cloned
genomic DNA (Accession No. FN601250).
Site-speciﬁc DNA inversion of the UU172 element in
U. parvum serovar 3 strain V892
The organization of the UU172 element in clonal variant
V892-K2 was unique among the observed serovar 3
strains, as it predominantly expressed a fusion protein
that contained both UU172 and UU171 and a partial
sequence of UU144 (Fig. 1). To investigate antigenic
variation in this clonal variant, selective antibody pressure
was directed against the C-terminal part of UU172 with
Pab a-U172C. Populations before and after selective
pressure were investigated by Southern blot analyses and
by cloning and sequencing of genomic DNA of the UU172
element. The cloned genomic DNA showed that at least
two variations of the UU172 element had evolved after
selective antibody pressure; one where the locus arrange-
ment was unaltered, but a mutation had appeared in the
5′ region of UU172C (Accession No. FN601256), and
another where an inversion had occurred, in which part of
the ORF UU143 was fused to UU172C (Accession No.
FN601257) and UU172N was fused to the C-terminal part
of UU143 (Fig. 7A). Southern blot analysis of EcoRV- and
BglII-digested genomic DNA conﬁrmed these results,
detecting both the original and an altered locus conﬁgu-
ration (Fig. 7B). BglII was chosen, as one restriction site
lies outside the UU172 element in ORF UU173 and
another in the ORF UU143 within the inverted fragment.
The restriction site is relocated after inversion, which
could be detected with the probes #143, #172N and
#172C. Two subclones were isolated from the population
after selective antibody pressure, each possessing one of
the genomic arrangements described above. Fusion of
the UU172N sequence with the C-terminal part of ORF
UU143 in subclone B was shown by PCR analysis
(Fig. 7C). Sequencing of the PCR product showed that
the fusion between UU172N and UU143 was in frame.
The same gene fusion could not be detected by PCR
analysis in subclone A.
Discussion
Phase switching of genes expressing surface membrane
protein antigens is not uncommon in the genus Myco-
plasma (Yogev et al., 2002; Citti et al., 2010). It is an
important microbial strategy for host adaptation and
evasion of immune responses to maintain diversity in a
propagating population. Well-described examples of
phase-variable loci include the vsp genes of Mycoplasma
bovis (Lysnyansky et al., 2001a,b), the vsa genes of
Mycoplasma pulmonis (Bhugra and Dybvig, 1992; Bhugra
et al., 1995) and the vpma genes of Mycoplasma agalac-
tiae (Glew et al., 2000; 2002; Flitman-Tene et al., 2003;
Chopra-Dewasthaly et al., 2008). The mechanism gov-
erning phase variations in these species is thought to be
driven either by site-speciﬁc DNA inversions which link
the ORF of a silent gene to a unique active promoter,
as observed in the vsp genes of M. bovis and the vpma
genes of M. agalactiae (Lysnyansky et al., 2001b; Glew
et al., 2002; Flitman-Tene et al., 2003), or by juxtaposition
of a DNA sequence containing promoter, ribosome
binding site and 5′ terminal region of an ORF in front of the
3′ end of a previously silent gene, as reported for the vsa
genes in M. pulmonis (Bhugra et al., 1995; Shen et al.,
2000). The latter mechanism has recently been sug-
gested to occur within the mba locus of U. parvum serovar
3 (Zimmerman et al., 2009) and we suggest that it also
occurs in its UU172 element.
Based on sequence data from U. parvum serovar 3
strains and on the data provided by the J. Craig Venter
Institute for all 14 serovars, we propose that the three
ORFs designated UU144, UU171 and UU172 in U.
parvum serovar 3 strain ATCC 700970 comprise a phase-
variable element for expression of different surface
exposed proteins. The ORFs UU144 and UU171 of U.
parvum serovar 3 were both originally annotated as ‘con-
served hypothetical’ encoding putative proteins with
expected molecular weights of 27.8 kDa and 22.6 kDa
respectively (Glass et al., 2000). Here, we provide evi-
dence that neither ORF is expressed alone, but only in
conjunction with the N-terminal sequence of UU172. As
a result, these genes have been re-annotated in the
genome sequences of ATCC 700970 and the ATCC type
strains of all 14 known serovars.
The locus conﬁguration of the two sequenced U.
parvum serovar 3 strains differs from those of all investi-
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region comprising 26 potential ORFs (UU145–UU170). In
Fig. 1, we have divided the ORF UU144 of strain ATCC
700970 into three parts (a, b and c). Of these, part a,
which comprises 14 amino acids, only occurs in the fully
sequenced serovar 3 strains. We believe that, due to the
disruption of the UU171/144 fusion in the ATCC 700970
strain, and also in the type strainATCC 27815T, the 5′ end
of UU144 was falsely annotated and the ORF is actually a
pseudogene in these two strains. No band for the UU144
protein was detected by Western blot analysis of total
protein of U. parvum serovar 3 strain ATCC 27815T, indi-
cating that this ORF does not possess its own promoter
and consequently is not expressed in this strain. Part b of
UU144 comprises amino acids 15–35 (DYDVKLTNVKI-
ANIALNNDNV) in U. parvum, and was located at a differ-
ent site in variant V892-K2 (Fig. 1). The amino acids DYD
are the linker between the ORFs UU171 and UU144 in U.
parvum strains. Part c of UU144 comprises amino acids
36 up to the end, except in U. parvum serovar 6, where
the potential ORF is truncated due to a mutation.
The disruption of the UU171/144 fusion seems untypi-
cal and could not be observed in any of the investigated
serovar 3 strains. Rather, the ORF fusion UU171/144
seems to represent the prevalent genomic organization in
both species. Interestingly, the genomic fragment that dis-
rupts the ORF in the two sequenced serovar 3 strains is
located near the potentially size- and phase-variable mba
locus in U. parvum serovar 6 and in U. urealyticum sero-
vars 5, 7, 8, 10, 11 and 12. In several other strains, this
genomic region seems to be missing altogether, indicating
relocation or deletion of this region during evolution. With
microarray-based genome analysis, Momynaliev et al.
demonstrated that this region can be present or absent in
serovars 1, 3 and 6 (Momynaliev et al., 2007). They sug-
gested that, due to its genetic features, this region could
be a pathogenicity island deriving from foreign DNA. Inter-
estingly, an in silico-based deletion of the 20 kb sequence
Fig. 7. DNA inversion of the UU172 element in U. parvum serotype 3 clonal variant V892-K2.
A and B. (A) Schematic illustration of the DNA inversion event and (B) Southern blot analysis of V892-K2 before (P0) and after (P3) selective
pressure with Pab a-U172C. Genomic DNA was digested with BglII and EcoRV and hybridized with the DIG-11-dUTP-labelled probes (see
Table S3) indicated below the blots.
C. PCR analysis of subclones A and B with primer pairs 17/20, 17/22, 23/24 and 23/25 (see Table S3).
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UU144 and UU171 of strain ATCC 700970 results in the
UU172 locus organization shown in Fig. 1A. In U. urealyti-
cum serovar 10, the 20 kb region is ﬂanked by 22 bp
(TAATCGTGATTATTGAACCTTG) direct repeats. This,
and the fact that several potential integrase/recombinase
genes (e.g. UU145, a close homologue of ripX and
UU154, a close homologue of phage recombinase Bet)
are located on the 20 kb region, raise the questions if it is
a mobile element and if the direct repeats promote exci-
sion of the region.
By sequencing and through BLAST analyses, we could
identify at least six different locus conﬁgurations (Figs 1
and 7), and we suggest that the two major conﬁgurations
depicted in Fig. 1A and B are phase-variable at high
frequency in both U. parvum and U. urealyticum. Phase
variation of UU171 and UU172 expression were previ-
ously suggested to occur as a result of slipped-strand
mispairing at a poly-AT (AT9) tract located in the inter-
genic region between the ORFs (Rocha and Blanchard,
2002). Here we provide evidence that phase variation
occurs at two inverted repeat regions, of which one is
located in the ORF UU172 and another in the intergenic
spacer region between UU172 and UU171. Three 21-nt-
long inverted repeat regions, which were proposed for the
ON/OFF switching of the mba gene, were localized in the
mba locus (Zimmerman et al., 2009). Similar inverted
repeats, but with a different assembly, were found in the
UU172 element. The UU172 ORF contains a 51-
nucleotide-long sequence (TTAAATAATGATAATTTAAAT
TATCAAACAGTAACTTTTGAACAAGTTCCT) encoding
LNNDNLNYQTVTFEQVP, of which one part (TTAAAT
AATGATAAT) is also located in UU144 and another
part (TTAAATTATCAAACAGTAACTTTTGAACAAGTT
CCT) on the complementary strand of the intergenic
spacer region between UU172 and UU171 (Fig. 2). Inver-
sion seems to take place at all three regions, but seems to
be most frequent between the two long inverted repeats.
Inversion frequencies between UU172 and UU171/144
expression were measured in clonal variants with the
monospeciﬁc Pabs a-U144 and a-U172 (Fig. S4).
Approximately 1–2% of the populations were found to
spontaneously switch their expression to the opposite
side without the application of selective antibody
pressure. Switching was also observed as sectoring in
colony blots (Fig. 4D), indicating that phase variation in
expression occurs at high frequency. This result is in
agreement with previous results obtained for the mba
locus (Monecke et al., 2003) and indicates that phase
variation of the UU172 element must be a mechanical
event processed by speciﬁc enzymes. Determining the
exact switching frequency is, however, hampered by sec-
toring of the colonies and by point mutations within the
locus, such as the occasionally appearing mutation in
the 3′ region of UU172N, which leads to false-negative
detection.
Both orientations of the UU172 element encode poten-
tial membrane proteins, which are immunogenic in
rabbits. Hyperimmune antisera, which were generated
against whole-cell preparations of the two isolates DR1
and M14, reacted with the recombinant proteins, and the
reaction patterns was in agreement with the expression
proﬁles of the strains (Fig. S5), i.e. antiserum against DR1
reacted strongly with U172N and U172C and the antise-
rum against M14 reacted strongly with U144, U171 and
UU172N. Additional work is, however, necessary to prove
that both potential membrane proteins are indeed immu-
nogenic in the human host and that phase variation of the
UU172 element, as a consequence of immune evasion,
similarly occurs in vivo.
Size variation of proteins encoded by the UU172
element is achieved by point mutations within its ORFs. A
frequently observed mutation was an insertion of a thymi-
dine in the 3′ region of the inverted repeat. This mutation
causes a translational frameshift in the ORF, which results
in a truncated protein comprising only the N-terminal part
of UU172 (UU172N). Such mutations are not infrequent
among mycoplasmas and were described to occur within
short homopolymeric tracts of adenine residues (poly-A
region) located in the N-terminal encoding region of
the vaa gene of Mycoplasma hominis (Zhang and
Wise, 1997; 2001). The genomic sequence of U. parvum
serovar 6 also shows an alteration in another poly-A
region in the UU171/144 sequence, leading to a poten-
tially truncated protein upon in silico inversion of the data-
base sequence.
Other mutations observed that caused potential size
variation of proteins were the nonsense mutations
G1,132T (GAA→TAA) in clonal variant M14-K16 (Acces-
sion No. FN601249) and G490T (GAA→TAA) in sub-
clones of V892-K2, which had been exposed to Pab
a-U172C (Accession No. FN601256). Bands with equal
molecular weight to the one observed in M14-K16 were
also seen in Pab a-U172C-immunostained Western blots
of clonal populations of other strains, indicating that this
mutation occurs frequently. Since we never detected a
complete UU172 protein in the strain M14, we presume
that the mutation is either irreversible or reversion occurs
at very low frequency. Such a low frequency or irreversible
nonsense mutation, in which guanine is replaced with the
nucleotide thymidine, has been reported for the pvpA
gene of Mycoplasma gallisepticum, where the mutation
takes place consistently in the fourth GAA codon of a
poly-GAA tract (Boguslavsky et al., 2000).
Among the U. parvum serovar 3 strains and clonal
isolates, the clonal variant V892-K2 possesses an excep-
tional UU172 locus organization. Its chimeric gene
arrangement might yield valuable information about a
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out the genome. In this clonal variant, selective antibody
pressure led to an inversion at a completely different site
than expected. In subpopulations of this clonal variant, the
sequence encoding UU172N was fused to the C-terminal
part of the ORF UU143, suggesting that the UU172
element might expand even beyond the ORFs described
in this report. The new potential chimeric gene was in
frame at the inversion site. Inversion had taken place at
a site with the nucleotide sequence ATTTAAATTA. This
short homologous sequence appears within the long
inverted repeats mentioned above and it occurs in mul-
tiple copies within the UU172 element and the UU143
ORF. A similar sequence can be located in the suggested
inversion sites of the mba locus, where the sequence
reads ATTTGAATTA. If this short sequence would serve
as a core sequence for DNAinversion, the arrangement of
the UU172 element in V892-K2 could be explained as the
result of the two inversions depicted in Fig. 8, although
these inversion events could not be proven by PCR and
no genomes with the ﬁrst two locus organizations were
obtained by subcloning. Short inverted repeats of only 14
and even 9 bp, promoting site-speciﬁc DNA inversion,
have been suggested for ﬂagellar phase variation in Sal-
monella and for phase variation of the type 1 pili in E. coli
(Zieg and Simon, 1980; Abraham et al., 1985). In Myco-
plasma penetrans, inverted repeats of only 12 bp serve as
inversion sequences in the promoter regions of the mlp
genes (Horino et al., 2009). An alignment of inverted
repeat regions of 30 mlp genes showed that they all
differed from each other, suggesting that the active
recombinase MYPE2900 has ﬂexibility in recognizing the
recombination sites (Horino et al., 2009). A similar ﬂexible
mechanism could likewise exist in ureaplasmas.
All three sequenced U. urealyticum strainsATCC 27814
(serovar 2), ATCC 27816 (serovar 4) and ATCC 33696
(serovar 12) have the same novel UU172 element orga-
nization that deviates from the locus arrangement
depicted in Fig. 1A. Although this ‘original’ locus organi-
zation can be obtained by in silico inversion at two sites,
one within UU144 and the other in the intergenic spacer
region between UU172 and UU171, it is not clear if this
inversion had occurred as an error and if it is reversible.
Selective antibody pressure against the UU172 protein of
strain ATCC 33696 did not select for subclones with alter-
nating expression.
The questions remain which enzymes are responsible
for the DNA inversion and what is the core sequence
Fig. 8. Schematic illustration of possible DNA inversion events leading to the UU172 element observed in strain V892. In a ﬁrst inversion
event, part ‘b’ of the ORF UU144 was fused, in frame, to UU172C and UU172N was fused to part ‘c’ of UU144. In a second inversion event at
the inverted repeat ATTTAAATTAT, UU172N was joined, in frame, with the intergenic region in front of UU171, thereby creating a long ORF
comprising UU172N, UU171, part of UU144 and UU172C.
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plasma species, site-speciﬁc recombinases, exhibiting
high homology to the tyrosine site-speciﬁc recombinase
family proteins XerC/D of E. coli and RipX or CodV of
Bacillus subtilis, were found to be responsible for the DNA
inversions within the phase-variable loci (Ron et al., 2002;
Sitaraman et al., 2002; Chopra-Dewasthaly et al., 2008).
For U. parvum serovar 3, three such recombinases
were annotated (Glass et al., 2000), of which two, XerC
(UU222) and RipX (UU145), also occur in U. urealyticum
serovar 10. Current studies are in progress to investigate
the involvement of these recombinases in the proposed
DNA inversions.
Together with the mba locus, ureaplasmas possess at
least two sets of genes that use chromosomal inversion to
alter their surface antigen expression. Since infections
with either Ureaplasma species are in most cases asymp-
tomatic, an intriguing question to be resolved is to eluci-
date the role that antigenic variation plays in the host
immune response and how antigenic variation correlates
with the ureaplasma pathogenicity. It has been reported
that the Triton X-114 detergent phase of U. parvum can
generate an inﬂammatory response by inducing the
nuclear factor NF-kB through the Toll-like receptor TLR2
(Shimizu et al., 2008). Since the MBA was only one of
several components responsible for this inﬂammatory
response, we speculate that recognition of both antigenic
variants could be a cause of ureaplasma disease. In this
scenario, patients who only recognize the dominant form
of MBA and UU172 would only develop a minor inﬂam-
matory response without any symptoms. Phase variation
in both the mba locus and the UU172 element could then
elevate the inﬂammatory response. Alternatively, expres-
sion of the fusion protein UU171/144 or loss of expression
due to mutations could camouﬂage the organism so that it
would be capable of evading the immune response and
execute its host-damaging effect via its virulence factors.
Interestingly, only one of the ﬁve patient isolates analysed
in this study showed predominant expression of UU172.
Also, most of the 14 ATCC type strains express the same
~500-amino-acid version of UU172, which could be
the consequence of prolonged laboratory passaging.
Knowing how ureaplasmas change their antigenic
make-up could be critical in understanding why a minority
of patients develop clinical symptoms like non-gonococcal
urethritis or a variety of adverse pregnancy outcomes.
Experimental procedures
Ureaplasma clonal variants and cultivation
Six clonal variants of U. parvum serovar 3 strains were used:
a clonal variant of type strain ATCC 27815
T (27815
T-K5) and
ﬁve clonal variants (Kn) from clinical isolates DR1, M14,
V892, V890 and V397 (DR1-K1, M14-K16, V892-K2, V890-
K12 and V397-K18 respectively). Clonal variants derived
from single colonies of the corresponding strain. Additionally,
the following U. urealyticum strains were used: serovar 9
(strain ATCC 33175), serovar 10 (strain Western CX3) and
serovar 12 (strain JSL-U24-CX3) (MacKenzie et al., 1996).
Ureaplasma strains and clonal variants were cultivated in
ureaplasma medium (UPM) as previously described (Zim-
merman et al., 2009).
Recombinant proteins
Four recombinant proteins were expressed as fusion proteins
with the maltose-binding protein using the expression vector
pMAL™-c2X and puriﬁed by affinity chromatography as
described by the manufacturer (New England BioLabs).
Brieﬂy, DNAwas extracted as described (Dumke et al., 2003)
from U. parvum type strain ATCC 27815
T and used as tem-
plate for PCR. PCR products were ampliﬁed with Pfu Poly-
merase (Fermentas Life Science) and primers (Table S3)
containing speciﬁc endonuclease cleavage sites (5′ BamHI
and 3′ HindIII or SalI) and designed for in-frame fusion with
the malE gene. To eliminate the three UGA codons in con-
struct U172C, four PCR products were synthesized and
fused by either blunt end or NheI site-speciﬁc ligation. All
cloned products were sequenced (GATC-Biotech, Germany)
to conﬁrm their identity.
Monospeciﬁc polyclonal antibodies (Pabs)
Monospeciﬁc hyperimmune antisera were generated in
rabbits against each of the recombinant proteins (Table S3)
using a protocol previously described (Ruhnke and Rosen-
dal, 1994).
Serial transfer in the presence of monospeciﬁc Pabs
Ureaplasma clonal variants were passaged three times in
UPM containing either a-U172C or a-U144. Prior to addition
to media, sera were incubated at 56°C for 30 min to inactivate
complement components. Ureaplasma cultures containing
10
3–10
4 colony-forming units (cfu) per ml were incubated for
24 h at 37°C with Pabs at dilutions of 1:10 or 1:100. The
next-day cultures were diluted to contain 10
3–10
4 cfu ml
-1 and
were passaged twice more under the same conditions.
For Western blot analysis, cells before antibody treatment
(P0) and from the third antibody-treated passage (P3) were
incubated in 500 ml of UPM at 37°C for 24 h without the
selective pressure of Pabs. Cells were centrifuged and
washed as previously described (Monecke et al., 2003).
To obtain colonies for preparing colony immunoblots, cells
before antibody treatment and from the third antibody-treated
passage were diluted and incubated on UPM agar for 48 h at
37°C and 5% CO2.
Immunostaining of colony blots by double
immunoﬂuorescence
Double immunoﬂuorescence of colony blots was carried out
as described (Duffy et al., 1998), except that 1¥ Roti®-Block
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clonal populations of clonal variant M14-K16, which had been
exposed to a-U144, were incubated on UPM agar and trans-
ferred onto nitrocellulose. As primary antibody, to detect
UU171/144-expressing cells, a-U144 (1:500) was used and
labelled with a Texas red-conjugated a-rabbit IgG (Acris Anti-
bodies) (1:1 000) as secondary antibody. The protocol was
repeated with a-U172C (1:500) as primary and a FITC-
conjugated a-rabbit IgG (Acris Antibodies) (1:1000) as sec-
ondary antibody to counterstain the colonies. Images of
colonies were made with an Olympus AX70 ﬂuorescence
microscope and a 20¥ objective with the ﬂuorescence
imaging software cell∧F. Colours were reversed for better
illustration.
Triton X-114 phase partitioning
Triton X-114 phase partitioning was carried out as described
(Kiarie et al., 1996) with cells from 1 l of ureaplasma culture,
except that proteins were methanol/chloroform-precipitated.
Proteins from the hydrophilic phases were resuspended in
200 ml and from hydrophobic phases in 100 ml of sample
buffer. For SDS-PAGE analysis, proteins of 20 ml of samples
per run were separated in 12.5% gels.
Southern blot analyses
Genomic DNA was isolated as described (Dumke et al.,
2003) from 500 ml of U. parvum serotype 3 cultures. DNA
pellets were air-dried and resuspended in 100 mlo fH 2O
for digestion with site-speciﬁc restriction endonucleases.
Genomic DNA derived from DR1-K1 and M14-K16 was
digested with 50 U of BglII (Fermentas Life Science) and
50 U of HincII (New England BioLabs) overnight at 37°C.
Genomic DNAderiving from V892-K2 was digested with 50 U
of BglII (Fermentas Life Sciences) and 50 U of EcoRV (Fer-
mentas Life Sciences). The digested DNA (20 ml lane
-1) was
separated in a 1% agarose gel and transferred to nylon
membranes (Sambrook et al., 1989).
Four DIG-11-dUTP (Roche Applied Science)-labelled PCR
products were synthesized for use as hybridization probes
(Table S3): one from UU171 (#171), one from the corre-
sponding N-terminal sequence of UU172 (#172N), one from
the corresponding C-terminal part of UU172 (#172C) and one
from the corresponding C-terminal sequence of ORF UU143
(#143). Hybridization and detection were carried out as
described (Chopra-Dewasthaly et al., 2005).
Sequencing of the UU172 element
Genomic DNA was isolated and digested with BglII as
described above. The digested DNA was ligated into the
unique BamHI site of the vector pBC (Stratagene), and E. coli
strain DH10B was transformed with the plasmids using the
heat shock method. Positive clones were screened in colony
blots with the DIG-11-dUTP-labelled PCR probes #171 or
#172C (see Table S3). Plasmid inserts were sequenced by
GATC-Biotech (Konstanz, Germany) and sequences were
submitted to the DDBJ/EMBL/GenBank databases under
the Accession No. FN601248, FN601249, FN601250,
FN601251, FN601252, FN601253, FN601254, FN601255,
FN601256 and FN601257.
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